We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
Ampronix,  Inc

Download Mobile App




Events

ATTENTION: Due to the COVID-19 PANDEMIC, many events are being rescheduled for a later date, converted into virtual venues, or altogether cancelled. Please check with the event organizer or website prior to planning for any forthcoming event.

Image: Nurse Winnie Kibirige sets up the ECGF-IS at Kiruddu Hospital in Kampala (Photo courtesy of UIRI)

Electronically Controlled Infusion System Reduces Mortality

An electronically controlled gravity-feed infusion set (ECGF-IS) can reduce mortality associated with intravenous (IV) infusions in developing countries. More...
22 Sep 2020
Image: AI-Based Digital Biomarker Could Assist in Early Intervention in High-Risk COVID-19 Patients (Photo courtesy of Business Wire)

AI-Based Digital Biomarker Could Assist in Early Intervention in High-Risk COVID-19 Patients

A first-in-kind tool that collects and analyzes continuous physiologic data could provide early clinical indicators of COVID-19 decompensation, offering healthcare providers invaluable insight necessary to intervene earlier and reduce poor patient outcome. More...
22 Sep 2020
Illustration

Common Allergy Nasal Spray Medication Shows Potent Efficacy Against SARS-CoV-2

A common allergy nasal spray medication containing azelastine has shown to have potent efficacy against SARS-CoV-2 in a human 3D nasal tissue model. More...
22 Sep 2020
Illustration

Experimental Cancer Drug Inhibits SARS-CoV-2 Virus from Infecting Cells and Replicating

A team of scientists has discovered that an experimental cancer drug called AR-12 inhibits the SARS-CoV-2 virus from infecting cells and replicating. More...
22 Sep 2020
Illustration

Dual Bronchodilator and Anti-Inflammatory COPD Drug Offers Potential for COVID-19 Treatment

A dual bronchodilator and anti-inflammatory drug originally developed for COPD is currently being studied to evaluate its effects on hospitalized COVID-19 patients due to its pronounced bronchodilator effects. More...
22 Sep 2020
Illustration

Ortho Awarded BARDA Contract to Accelerate Development of SARS-CoV-2 Antigen Test

Ortho Clinical Diagnostics (Raritan, NJ, USA) has been awarded USD 12,850,000 by the Biomedical Advanced Research and Development Authority (BARDA) to support the development of the company's SARS-CoV-2 antigen test and continued regulatory pathway support for its total and IgG antibody tests. More...
22 Sep 2020
Image: Menarini Diagnostics Launches New SARS-CoV-2 Antigen Test That Also Measures Viral Load (Photo courtesy of A. Menarini Diagnostics)

Menarini Diagnostics Launches New SARS-CoV-2 Antigen Test That Also Measures Viral Load

A new COVID-19 test from A. Menarini Diagnostics (Florence, Italy) to detect the presence of antigens can not only determine whether a patient is positive for COVID-19, but also provide an indication of the viral load, allowing the most infectious and most at-risk patients to be identified immediately. More...
22 Sep 2020
Copyright © 2000-2020 Globetech Media. All rights reserved.